Armata Pharmaceuticals Inc ARMP

US Biotechnology

$3.74 ▲ +3.31% (+$0.12)

Open $3.60

Prev Close $3.62

Day Range $3.56 – $3.81

52W Range $2.94 – $16.34

Market Cap $139.06M

Beta 1.56

EPS (TTM) $-6.12

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NYSE MKT LLC
Currency	USD
IPO Date	1994-05-20
Shares Out.	36,710,000
Website	armatapharma.com/ ↗
Phone	13106652928
Employees	61
Revenue	$2.5M
Gross Profit	$2.5M
Net Income	$74.1M
Free Cash Flow	-$25.8M
Total Assets	$90.0M
Total Liabilities	$321.1M
Equity	-$231.2M

About Armata Pharmaceuticals Inc

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Armata Pharmaceuticals Inc is a publicly traded company under the ticker symbol ARMP on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.